The European Healthcare Information Technology (HCIT) and Artificial Intelligence (AI) mergers and acquisitions landscape is currently navigating a period of profound structural transformation. Following the exuberant valuation cycles of 2020-2021 and the subsequent correction, the 2024-2025 period is defined by a "flight to quality" and a rigorous emphasis on clinical utility over theoretical potential. For Venture Capital (VC) funds operating across the continent, the s